Management of childhood leukemia.
D000476:Alkanesulfonates / Q000627:therapeutic use; D000578:Amidines / Q000627:therapeutic use; D001856:Bone Marrow Examination; D002644:Chickenpox / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007945:Leukemia, Lymphoid / Q000175:diagnosis / Q000628:therapy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009422:Nervous System Diseases / Q000188:drug therapy / Q000517:prevention & control / Q000532:radiotherapy; D010647:Phenyl Ethers / Q000627:therapeutic use; D010817:Physician-Patient Relations; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control; D011241:Prednisone / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000209:etiology; D012008:Recurrence; D013736:Testicular Neoplasms / Q000532:radiotherapy; D014750:Vincristine / Q000627:therapeutic use; D005719:gamma-Globulins / Q000627:therapeutic use
D000476:Alkanesulfonates; D000578:Amidines; D010647:Phenyl Ethers; D005719:gamma-Globulins; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate